BIOMAT Database Logo BIOMAT Database Logo

High molecular weight neutrophil chemotactic activity in asthma and related disorders. 1986

A B Kay, and J A MacKay

UI MeSH Term Description Entries
D008168 Lung Either of the pair of organs occupying the cavity of the thorax that effect the aeration of the blood. Lungs
D008970 Molecular Weight The sum of the weight of all the atoms in a molecule. Molecular Weights,Weight, Molecular,Weights, Molecular
D002630 Chemotactic Factors Chemical substances that attract or repel cells. The concept denotes especially those factors released as a result of tissue injury, microbial invasion, or immunologic activity, that attract LEUKOCYTES; MACROPHAGES; or other cells to the site of infection or insult. Chemoattractant,Chemotactic Factor,Chemotaxin,Chemotaxins,Cytotaxinogens,Cytotaxins,Macrophage Chemotactic Factor,Chemoattractants,Chemotactic Factors, Macrophage,Macrophage Chemotactic Factors,Chemotactic Factor, Macrophage,Factor, Chemotactic,Factor, Macrophage Chemotactic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000485 Allergens Antigen-type substances that produce immediate hypersensitivity (HYPERSENSITIVITY, IMMEDIATE). Allergen
D001249 Asthma A form of bronchial disorder with three distinct components: airway hyper-responsiveness (RESPIRATORY HYPERSENSITIVITY), airway INFLAMMATION, and intermittent AIRWAY OBSTRUCTION. It is characterized by spasmodic contraction of airway smooth muscle, WHEEZING, and dyspnea (DYSPNEA, PAROXYSMAL). Asthma, Bronchial,Bronchial Asthma,Asthmas
D001250 Asthma, Exercise-Induced Asthma attacks following a period of exercise. Usually the induced attack is short-lived and regresses spontaneously. The magnitude of postexertional airway obstruction is strongly influenced by the environment in which exercise is performed (i.e. inhalation of cold air during physical exertion markedly augments the severity of the airway obstruction; conversely, warm humid air blunts or abolishes it). Bronchospasm, Exercise-Induced,Exercise-Induced Asthma,Exercise-Induced Bronchospasm,Asthma, Exercise Induced,Bronchospasm, Exercise Induced,Exercise Induced Asthma,Exercise Induced Bronchospasm,Exercise-Induced Asthmas,Exercise-Induced Bronchospasms
D016209 Interleukin-8 A member of the CXC chemokine family that plays a role in the regulation of the acute inflammatory response. It is secreted by variety of cell types and induces CHEMOTAXIS of NEUTROPHILS and other inflammatory cells. CXCL8 Chemokine,Chemokine CXCL8,Chemotactic Factor, Macrophage-Derived,Chemotactic Factor, Neutrophil, Monocyte-Derived,IL-8,Neutrophil-Activating Peptide, Lymphocyte-Derived,Neutrophil-Activating Peptide, Monocyte-Derived,AMCF-I,Alveolar Macrophage Chemotactic Factor-I,Anionic Neutrophil-Activating Peptide,Chemokines, CXCL8,Chemotactic Factor, Neutrophil,Granulocyte Chemotactic Peptide-Interleukin-8,IL8,Monocyte-Derived Neutrophil Chemotactic Factor,Neutrophil Activation Factor,Alveolar Macrophage Chemotactic Factor I,Anionic Neutrophil Activating Peptide,CXCL8 Chemokines,CXCL8, Chemokine,Chemokine, CXCL8,Chemotactic Factor, Macrophage Derived,Chemotactic Peptide-Interleukin-8, Granulocyte,Granulocyte Chemotactic Peptide Interleukin 8,Interleukin 8,Lymphocyte-Derived Neutrophil-Activating Peptide,Macrophage-Derived Chemotactic Factor,Monocyte-Derived Neutrophil-Activating Peptide,Neutrophil Activating Peptide, Lymphocyte Derived,Neutrophil Activating Peptide, Monocyte Derived,Neutrophil Chemotactic Factor,Neutrophil-Activating Peptide, Anionic,Peptide, Anionic Neutrophil-Activating

Related Publications

A B Kay, and J A MacKay
High molecular weight-neutrophil chemotactic activity in nasal allergy.
January 1989, Allergy proceedings : the official journal of regional and state allergy societies,
A B Kay, and J A MacKay
Release of high molecular weight neutrophil chemotactic activity from human cultured basophilic cells.
October 1987, Acta paediatrica Japonica : Overseas edition,
A B Kay, and J A MacKay
Release of high molecular weight-neutrophil chemotactic activity from human tissues, cells and secretion.
January 1989, International archives of allergy and applied immunology,
A B Kay, and J A MacKay
Neutrophil chemotactic activity in milk-induced asthma.
July 1983, The Journal of allergy and clinical immunology,
A B Kay, and J A MacKay
Neutrophil chemotactic factors and related clinical disorders.
January 1970, Arthritis and rheumatism,
A B Kay, and J A MacKay
Serum neutrophil chemotactic activity and exercise induced asthma.
April 1983, European journal of respiratory diseases,
A B Kay, and J A MacKay
Release of high-molecular-weight neutrophil chemotactic activity from resected human nasal turbinate after antigen challenge.
March 1989, The Journal of allergy and clinical immunology,
A B Kay, and J A MacKay
Properties of a high molecular weight neutrophil chemotactic factor, possibly derived from mast cells: evidence for chemokinetic rather than chemotactic activity.
April 1984, Agents and actions,
A B Kay, and J A MacKay
Neutrophil chemotactic activity in toluene diisocyanate (TDI)-induced asthma.
March 1990, The Journal of allergy and clinical immunology,
A B Kay, and J A MacKay
Neutrophil chemotactic activity in acute severe asthma (status asthmaticus).
December 1987, The American review of respiratory disease,
Copied contents to your clipboard!